Accessibility Menu
 
Veracyte logo

Veracyte

(NASDAQ) VCYT

Current Price$32.20
Market Cap$2.57B
Since IPO (2013)+145%
5 Year-39%
1 Year+7%
1 Month-8%

Veracyte Financials at a Glance

Market Cap

$2.57B

Revenue (TTM)

$517.14M

Net Income (TTM)

$66.35M

EPS (TTM)

$0.82

P/E Ratio

39.45

Dividend

$0.00

Beta (Volatility)

1.90 (High)

Price

$32.20

Volume

19,272

Open

$31.54

Previous Close

$32.20

Daily Range

$31.54 - $33.03

52-Week Range

$22.61 - $50.71

VCYT: Motley Fool Moneyball Superscore

75

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Veracyte

Industry

Biotechnology

Employees

755

CEO

Marc A. Stapley

Headquarters

South San Francisco, CA 94080, US

VCYT Financials

Key Financial Metrics (TTM)

Gross Margin

71%

Operating Margin

9%

Net Income Margin

13%

Return on Equity

5%

Return on Capital

3%

Return on Assets

5%

Earnings Yield

2.53%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.57B

Shares Outstanding

79.46M

Volume

19.27K

Short Interest

0.00%

Avg. Volume

925.41K

Financials (TTM)

Gross Profit

$360.05M

Operating Income

$74.15M

EBITDA

$89.62M

Operating Cash Flow

$136.31M

Capital Expenditure

$9.68M

Free Cash Flow

$126.63M

Cash & ST Invst.

$412.89M

Total Debt

$39.65M

Veracyte Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$140.64M

+18.5%

Gross Profit

$104.68M

+32.9%

Gross Margin

74.43%

N/A

Market Cap

$2.57B

N/A

Market Cap/Employee

$3.12M

N/A

Employees

824

N/A

Net Income

$41.15M

+704.8%

EBITDA

$45.93M

+373.7%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$373.24M

+56.4%

Accounts Receivable

$44.66M

-4.0%

Inventory

$20.55M

-5.5%

Long Term Debt

$35.60M

-17.7%

Short Term Debt

$4.05M

-46.0%

Return on Assets

4.72%

N/A

Return on Invested Capital

3.46%

N/A

Free Cash Flow

$48.27M

+136.8%

Operating Cash Flow

$52.58M

+114.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IRONDisc Medicine, Inc.
$65.18+0.62%
ADPTAdaptive Biotechnologies Corporation
$14.81+2.63%
IDYAIDEAYA Biosciences, Inc.
$32.74+0.80%
ZLABZai Lab Limited
$20.41+0.34%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.31-0.02%

Questions About VCYT

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.